Late onset neuromyelitis optica spectrum disorder with anti‐aquaporin 4 and anti‐myelin oligodendrocyte glycoprotein antibodies

Late onset neuromyelitis optica spectrum disorder with anti‐aquaporin 4 and anti‐myelin oligodendrocyte glycoprotein antibodies

Background and purpose This study aimed to evaluate the clinical characteristics and prognosis of late onset (≥50 years) neuromyelitis optica spectrum disorder (LO‐NMOSD), and compare them with those of early onset (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2022-04, Vol.29 (4), p.1128-1135
Hauptverfasser: Wang, Liang, Tan, Hongmei, Huang, Wenjuan, Chang, Xuechun, ZhangBao, Jingzi, Zhou, Lei, Lu, Chuanzhen, Wang, Min, Lu, Jiahong, Zhao, Chongbo, Quan, Chao
Format: Artikel
Sprache:eng
Schlagworte:
Age
Antibodies
antibody
Aquaporin 4
Aquaporins
Blindness
Glycoproteins
Inflammatory diseases
Medical records
Myelin
myelin oligodendrocyte glycoprotein
Myelitis
Neuromyelitis
neuromyelitis optica spectrum disorder
Oligodendrocyte-myelin glycoprotein
Patients
Prognosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and purpose This study aimed to evaluate the clinical characteristics and prognosis of late onset (≥50 years) neuromyelitis optica spectrum disorder (LO‐NMOSD), and compare them with those of early onset (
ISSN:1351-5101
1468-1331
DOI:10.1111/ene.15239